Glass House Brands Inc
Glass House Brands Inc
- Market cap
- $110.27M
Your view on GLAS
Overview
What the company does, where it operates, and who runs it.
About Glass House Brands Inc
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kyle Kazan
- Headquarters
- 3645 Long Beach Boulevard, Long Beach, CA, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kyle Kazan
- Headquarters
- 3645 Long Beach Boulevard, Long Beach, CA, US
Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities.
The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Glass House Brands Inc. Starting points for Glass House Brands Inc: EPS -$0.51, beta 0.51 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Glass House Brands Inc. Trailing twelve-month EPS for Glass House Brands Inc stands at -$0.51. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
1 rating- Strong Buy0
- Buy1
- Hold0
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterSep 2024 | Next quarterDec 2024 | This yearYear to Dec 2024 | Next yearYear to Dec 2025 |
|---|---|---|---|---|
| Average estimate | $0.01 | −$0.10 | −$0.35 | −$0.41 |
| Lowest estimate | $0.00 | −$0.11 | −$0.37 | −$0.43 |
| Highest estimate | $0.01 | −$0.10 | −$0.34 | −$0.39 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Revenue estimates
| Total | This quarterSep 2024 | Next quarterDec 2024 | This yearYear to Dec 2024 | Next yearYear to Dec 2025 |
|---|---|---|---|---|
| Average estimate | $65.80M | $50.38M | $199.14M | $182.38M |
| Lowest estimate | $61.45M | $47.95M | $192.73M | $176.51M |
| Highest estimate | $69.59M | $52.81M | $207.77M | $190.28M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Glass House Brands Inc. Glass House Brands Inc has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| XTXXFAdastra Holdings Ltd. | Healthcare | OTC | $55,971 | ||
| YCBDcbdMD, Inc. | Healthcare | AMEX | $4.0M | ||
| YOURFYourWay Cannabis Brands Inc. | Healthcare | OTC | $2,879 | ||
| ZTSZoetis Inc. | Healthcare | NYSE | $32.1B | ||
| ZYBTZhengye Biotechnology Holding Limited | Healthcare | NASDAQ | $70.1M | ||
| TSND.TOTerrAscend Corp. | Healthcare | TSX | $160.1M | ||
| TSNDFTerrAscend Corp. | Healthcare | OTC | $259.7M | ||
| TWAPFTowa Pharmaceutical Co., Ltd. | Healthcare | OTC | $828.5M | ||
| TWSITristar Wellness Solutions Inc. | Healthcare | OTC | $1.9M | ||
| TXMDTherapeuticsMD, Inc. | Healthcare | NASDAQ | $19.8M | ||
| ULIHFThe United Laboratories International Holdings Limited | Healthcare | OTC | $3.2B | ||
| UPCUniverse Pharmaceuticals Inc. | Healthcare | NASDAQ | $682,302 | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Glass House Brands Inc executives and directors. Shares of Glass House Brands Inc have traded between $9.12 and $13.19 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Glass House Brands Inc. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Glass House Brands Inc. Coverage tracks Glass House Brands Inc within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Glass House Brands Inc.